Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.63 is 51% below its 5-year average of 5.41, near the low end of its 5-year range (0.71–13.28).
As of the fiscal period ended Tuesday, June 30, 2026. 1.66% below its 12-month average of 2.67.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.63.
QUICK RATIO (ACID-TEST)
2.63
QUICK RATIO (ACID-TEST) AVG TTM
2.67
QUICK RATIO (ACID-TEST) AVG 3Y
3.43
QUICK RATIO (ACID-TEST) AVG 5Y
5.41
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-1.66%
CURRENT VS 3Y AVG
-23.44%
CURRENT VS 5Y AVG
-51.42%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.28
median of 803 covered companies
CURRENT VS SECTOR MEDIAN
-19.85%
vs the sector median at left
Longeveron Inc.
Market Cap
$7.27M
Quick Ratio (Acid-Test)
2.63
TTM Avg
2.67
3Y Avg
3.43
5Y Avg
5.41
Market Cap
$7.31M
Quick Ratio (Acid-Test)
1.37
TTM Avg
3.92
3Y Avg
4.12
5Y Avg
3.73
Market Cap
$7.40M
Quick Ratio (Acid-Test)
0.95
TTM Avg
9.81
3Y Avg
5.30
5Y Avg
4.51
Market Cap
$7.08M
Quick Ratio (Acid-Test)
0.31
TTM Avg
1.26
3Y Avg
1.91
5Y Avg
5.52
Market Cap
$7.00M
Quick Ratio (Acid-Test)
0.18
TTM Avg
0.90
3Y Avg
2.06
5Y Avg
1.76
Market Cap
$6.99M
Quick Ratio (Acid-Test)
2.61
TTM Avg
3.40
3Y Avg
4.86
5Y Avg
5.09
Market Cap
$6.90M
Quick Ratio (Acid-Test)
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$7.66M
Quick Ratio (Acid-Test)
14.52
TTM Avg
3.29
3Y Avg
11.30
5Y Avg
10.20
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Longeveron Inc. (LGVN) | $7.27M | 2.63 | 2.67 | 3.43 | 5.41 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | 1.37 | 3.92 | 4.12 | 3.73 |
| Skye Bioscience, Inc. (SKYE)vs › | $7.40M | 0.95 | 9.81 | 5.30 | 4.51 |
| KALA BIO, Inc. (KALA)vs › | $7.08M | 6.88 | 3.46 | 4.15 | 4.53 |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.08M | 0.31 | 1.26 | 1.91 | 5.52 |
| Mangoceuticals, Inc. (MGRX)vs › | $7.00M | 0.18 | 0.90 | 2.06 | 1.76 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.99M | 2.61 | 3.40 | 4.86 | 5.09 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $6.90M | 45.95 | 58.73 | 40.89 | 40.89 |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.66M | 14.52 | 3.29 | 11.30 | 10.20 |
| Exicure, Inc. (XCUR)vs › | $6.82M | 0.56 | 2.82 | 3.15 | 3.36 |
Quick Ratio
2.63
Excludes inventory
Current Ratio
2.63
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.63 |
| 2026-03-31 | 3.88 |
| 2025-12-31 | 1.33 |
| 2025-09-30 | 2.09 |
| 2025-06-30 | 3.43 |
| 2025-03-31 | 5.61 |
| 2024-12-31 | 7.60 |
| 2024-09-30 | 7.67 |
| 2024-06-30 | 4.18 |
| 2024-03-31 | 0.71 |
| 2023-12-31 | 1.50 |
| 2023-09-30 | 1.49 |
| 2023-06-30 | 2.52 |
| 2023-03-31 | 4.14 |
| 2022-12-31 | 4.17 |
| 2022-09-30 | 6.25 |
| 2022-06-30 | 7.80 |
| 2022-03-31 | 13.28 |
| 2021-12-31 | 13.06 |
| 2021-09-30 | 10.18 |
| 2021-06-30 | 10.12 |
| 2021-03-31 | 9.10 |
| 2020-12-31 | 0.48 |
| 2020-09-30 | 0.76 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.95 |
